https://stock.noler.com/us/stock/onco https://stock.noler.com/us/stock/onco/13f-holdings https://stock.noler.com/us/stock/onco/accelerated-share-repurchases-final-price-paid-per-share https://stock.noler.com/us/stock/onco/accounts-payable https://stock.noler.com/us/stock/onco/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/onco/accounts-payable-and-accrued-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/onco/accounts-payable-current-and-noncurrent https://stock.noler.com/us/stock/onco/accounts-payable-other-current-and-noncurrent https://stock.noler.com/us/stock/onco/accounts-receivable https://stock.noler.com/us/stock/onco/accounts-receivable-fair-value-disclosure https://stock.noler.com/us/stock/onco/accounts-receivable-gross-current https://stock.noler.com/us/stock/onco/accounts-receivable-net https://stock.noler.com/us/stock/onco/accounts-receivable-sale https://stock.noler.com/us/stock/onco/accrual-for-taxes-other-than-income-taxes-current https://stock.noler.com/us/stock/onco/accrued-employee-benefits-current https://stock.noler.com/us/stock/onco/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/onco/accrued-liabilities-current https://stock.noler.com/us/stock/onco/accrued-marketing-costs-current https://stock.noler.com/us/stock/onco/accrued-professional-fees-current https://stock.noler.com/us/stock/onco/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/onco/accrued-utilities-current-and-noncurrent https://stock.noler.com/us/stock/onco/acquired-inventory https://stock.noler.com/us/stock/onco/acquired-net https://stock.noler.com/us/stock/onco/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/onco/acquisition-consideration-transferred https://stock.noler.com/us/stock/onco/acquisition-consideration-transferred-including-equity-interest-in-acquiree-held-prior-to-combination https://stock.noler.com/us/stock/onco/acquisition-consideration-transferred-other https://stock.noler.com/us/stock/onco/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/onco/acquisition-provisional-information-initial-accounting-incomplete-adjustment-consideration-transferred https://stock.noler.com/us/stock/onco/acquisition-separately-recognized-transactions-additional-disclosures-acquisition-costs https://stock.noler.com/us/stock/onco/acquisition-step-acquisition-equity-interest-in-acquiree-remeasurement-gain-or-loss https://stock.noler.com/us/stock/onco/acquisitions https://stock.noler.com/us/stock/onco/activist-13d-13g https://stock.noler.com/us/stock/onco/additional-collateral-aggregate-fair-value https://stock.noler.com/us/stock/onco/additional-paid-in-capital https://stock.noler.com/us/stock/onco/additions-to-other-assets-amount https://stock.noler.com/us/stock/onco/adjustment-for-amortization https://stock.noler.com/us/stock/onco/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/onco/administrative-fees-expense https://stock.noler.com/us/stock/onco/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/onco/amended-reports-10-k https://stock.noler.com/us/stock/onco/amortization https://stock.noler.com/us/stock/onco/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/onco/amortization-of-financing-costs https://stock.noler.com/us/stock/onco/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/onco/analyst-ratings-buy https://stock.noler.com/us/stock/onco/analyst-ratings-hold https://stock.noler.com/us/stock/onco/analyst-ratings-no-rating https://stock.noler.com/us/stock/onco/analyst-ratings-sell https://stock.noler.com/us/stock/onco/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/onco/aoci https://stock.noler.com/us/stock/onco/asset-acquisition-consideration-transferred https://stock.noler.com/us/stock/onco/asset-acquisition-consideration-transferred-equity-interest-issued-and-issuable https://stock.noler.com/us/stock/onco/asset-acquisition-consideration-transferred-other-assets https://stock.noler.com/us/stock/onco/asset-acquisition-consideration-transferred-transaction-cost https://stock.noler.com/us/stock/onco/asset-acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/onco/asset-at-fair-value-changes-in-fair-value-resulting-from-changes-in-assumptions https://stock.noler.com/us/stock/onco/asset-impairment-charges https://stock.noler.com/us/stock/onco/auditor https://stock.noler.com/us/stock/onco/available-for-sale-debt-excluding-accrued-interest https://stock.noler.com/us/stock/onco/basic-shares https://stock.noler.com/us/stock/onco/business https://stock.noler.com/us/stock/onco/business-acquisition-cost-of-acquired-entity-transaction-costs https://stock.noler.com/us/stock/onco/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/onco/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/onco/buyback-authorization https://stock.noler.com/us/stock/onco/buybacks-payments-for-repurchase-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/onco/buybacks-share-repurchases https://stock.noler.com/us/stock/onco/buybacks-shares-repurchased https://stock.noler.com/us/stock/onco/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/onco/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/onco/capital-expenditures https://stock.noler.com/us/stock/onco/capital-units https://stock.noler.com/us/stock/onco/capitalized-contract-cost-impairment-loss https://stock.noler.com/us/stock/onco/cash https://stock.noler.com/us/stock/onco/cash-acquired-from-acquisition https://stock.noler.com/us/stock/onco/cash-and-equivalents https://stock.noler.com/us/stock/onco/cash-and-restricted-cash https://stock.noler.com/us/stock/onco/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/onco/cash-fdic-insured-amount https://stock.noler.com/us/stock/onco/cash-flow-breakdown https://stock.noler.com/us/stock/onco/cash-uninsured-amount https://stock.noler.com/us/stock/onco/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/onco/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/onco/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/onco/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/onco/class-of-warrant-or-right-unissued https://stock.noler.com/us/stock/onco/clinical-trials https://stock.noler.com/us/stock/onco/commitments-fair-value-disclosure https://stock.noler.com/us/stock/onco/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/onco/common-stock-convertible-conversion-price-increase https://stock.noler.com/us/stock/onco/common-stock-dividends-shares https://stock.noler.com/us/stock/onco/common-stock-no-par-value https://stock.noler.com/us/stock/onco/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/onco/common-stock-shares-subscribed-but-unissued https://stock.noler.com/us/stock/onco/common-stock-value https://stock.noler.com/us/stock/onco/common-unit-issued https://stock.noler.com/us/stock/onco/company-guidance https://stock.noler.com/us/stock/onco/company-profile https://stock.noler.com/us/stock/onco/compensated-absences-liability https://stock.noler.com/us/stock/onco/comprehensive-income https://stock.noler.com/us/stock/onco/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/onco/congressional-trades-stocks-including-adrs https://stock.noler.com/us/stock/onco/consideration-received-for-beneficial-interest-obtained-for-transferring-financial-asset https://stock.noler.com/us/stock/onco/contingent-consideration-classified-as-equity-fair-value-disclosure https://stock.noler.com/us/stock/onco/contractual-obligation https://stock.noler.com/us/stock/onco/contractual-obligation-future-minimum-payments-due-remainder-of-fiscal-year https://stock.noler.com/us/stock/onco/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/onco/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/onco/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/onco/convertible-long-term-notes-payable https://stock.noler.com/us/stock/onco/convertible-notes-payable-current https://stock.noler.com/us/stock/onco/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/onco/convertible-preferred-stock-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/onco/convertible-securities-retired https://stock.noler.com/us/stock/onco/cost-of-revenue https://stock.noler.com/us/stock/onco/costs-and-expenses https://stock.noler.com/us/stock/onco/costs-and-expenses-related-party https://stock.noler.com/us/stock/onco/cover-page-shares-outstanding https://stock.noler.com/us/stock/onco/credit-derivative-liquidation-proceeds-percentage https://stock.noler.com/us/stock/onco/cumulative-dividends https://stock.noler.com/us/stock/onco/current-assets https://stock.noler.com/us/stock/onco/current-income-tax-expense-benefit https://stock.noler.com/us/stock/onco/current-liabilities https://stock.noler.com/us/stock/onco/current-ratio https://stock.noler.com/us/stock/onco/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/onco/debt-conversion-converted-instrument-warrants-or-options-issued https://stock.noler.com/us/stock/onco/debt-equity-ratio https://stock.noler.com/us/stock/onco/debt-face-amount https://stock.noler.com/us/stock/onco/debt-issued-principal https://stock.noler.com/us/stock/onco/debt-unamortized-discount https://stock.noler.com/us/stock/onco/debt-unamortized-discount-current https://stock.noler.com/us/stock/onco/debt-unamortized-discount-premium-net https://stock.noler.com/us/stock/onco/deferred-compensation-arrangement-with-individual-cash-awards-granted-percentage https://stock.noler.com/us/stock/onco/deferred-costs https://stock.noler.com/us/stock/onco/deferred-costs-current https://stock.noler.com/us/stock/onco/deferred-costs-current-and-noncurrent https://stock.noler.com/us/stock/onco/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/onco/deferred-finance-costs-current-net https://stock.noler.com/us/stock/onco/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/onco/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/onco/deferred-income-tax-liabilities https://stock.noler.com/us/stock/onco/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/onco/deferred-offering-costs https://stock.noler.com/us/stock/onco/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/onco/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/onco/deferred-tax-assets-gross https://stock.noler.com/us/stock/onco/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/onco/deferred-tax-assets-net https://stock.noler.com/us/stock/onco/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/onco/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/onco/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/onco/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/onco/deferred-tax-assets-other https://stock.noler.com/us/stock/onco/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/onco/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/onco/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/onco/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-employee-benefits https://stock.noler.com/us/stock/onco/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-other https://stock.noler.com/us/stock/onco/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/onco/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/onco/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/onco/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/onco/deferred-tax-liabilities https://stock.noler.com/us/stock/onco/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/onco/deferred-tax-liabilities-other https://stock.noler.com/us/stock/onco/deferred-tax-liabilities-other-finite-lived-assets https://stock.noler.com/us/stock/onco/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/onco/defined-benefit-pension-plan-liabilities-noncurrent https://stock.noler.com/us/stock/onco/defined-benefit-plan-accumulated-benefit-obligation https://stock.noler.com/us/stock/onco/defined-benefit-plan-actual-return-on-plan-assets https://stock.noler.com/us/stock/onco/defined-benefit-plan-actuarial-gain-loss https://stock.noler.com/us/stock/onco/defined-benefit-plan-amortization-of-gains-losses https://stock.noler.com/us/stock/onco/defined-benefit-plan-assumptions-used-calculating-benefit-obligation-discount-rate https://stock.noler.com/us/stock/onco/defined-benefit-plan-assumptions-used-calculating-benefit-obligation-rate-of-compensation-increase https://stock.noler.com/us/stock/onco/defined-benefit-plan-assumptions-used-calculating-benefit-obligation-weighted-average-interest-crediting-rate https://stock.noler.com/us/stock/onco/defined-benefit-plan-assumptions-used-calculating-net-periodic-benefit-cost-discount-rate https://stock.noler.com/us/stock/onco/defined-benefit-plan-assumptions-used-calculating-net-periodic-benefit-cost-expected-long-term-return-on-assets https://stock.noler.com/us/stock/onco/defined-benefit-plan-assumptions-used-calculating-net-periodic-benefit-cost-rate-of-compensation-increase https://stock.noler.com/us/stock/onco/defined-benefit-plan-benefit-obligation https://stock.noler.com/us/stock/onco/defined-benefit-plan-benefit-obligation-benefits-paid https://stock.noler.com/us/stock/onco/defined-benefit-plan-benefit-obligation-contributions-by-plan-participant https://stock.noler.com/us/stock/onco/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/onco/defined-benefit-plan-curtailments https://stock.noler.com/us/stock/onco/defined-benefit-plan-expected-amortization-of-transition-asset-obligation-next-fiscal-year https://stock.noler.com/us/stock/onco/defined-benefit-plan-expected-future-benefit-payments-five-fiscal-years-thereafter https://stock.noler.com/us/stock/onco/defined-benefit-plan-expected-future-benefit-payments-next-twelve-months https://stock.noler.com/us/stock/onco/defined-benefit-plan-expected-future-benefit-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/onco/defined-benefit-plan-expected-future-benefit-payments-year-five https://stock.noler.com/us/stock/onco/defined-benefit-plan-expected-future-benefit-payments-year-four https://stock.noler.com/us/stock/onco/defined-benefit-plan-expected-future-benefit-payments-year-three https://stock.noler.com/us/stock/onco/defined-benefit-plan-expected-future-benefit-payments-year-two https://stock.noler.com/us/stock/onco/defined-benefit-plan-expected-return-on-plan-assets https://stock.noler.com/us/stock/onco/defined-benefit-plan-fair-value-of-plan-assets https://stock.noler.com/us/stock/onco/defined-benefit-plan-funded-status-of-plan https://stock.noler.com/us/stock/onco/defined-benefit-plan-interest-cost https://stock.noler.com/us/stock/onco/defined-benefit-plan-net-periodic-benefit-cost https://stock.noler.com/us/stock/onco/defined-benefit-plan-other-changes https://stock.noler.com/us/stock/onco/defined-benefit-plan-pension-plan-with-projected-benefit-obligation-in-excess-of-plan-assets-projected-benefit-obligation https://stock.noler.com/us/stock/onco/defined-benefit-plan-pension-plans-with-accumulated-benefit-obligations-in-excess-of-plan-assets-aggregate-fair-value-of-plan-assets https://stock.noler.com/us/stock/onco/defined-benefit-plan-plan-amendments https://stock.noler.com/us/stock/onco/defined-benefit-plan-plan-assets-benefits-paid https://stock.noler.com/us/stock/onco/defined-benefit-plan-plan-assets-contributions-by-plan-participant https://stock.noler.com/us/stock/onco/defined-benefit-plan-recognized-net-gain-loss-due-to-curtailments https://stock.noler.com/us/stock/onco/defined-benefit-plan-recognized-net-gain-loss-due-to-settlements https://stock.noler.com/us/stock/onco/defined-benefit-plan-recognized-net-gain-loss-due-to-settlements-and-curtailments https://stock.noler.com/us/stock/onco/defined-benefit-plan-service-cost https://stock.noler.com/us/stock/onco/defined-benefit-plan-settlements-benefit-obligation https://stock.noler.com/us/stock/onco/defined-benefit-plan-settlements-plan-assets https://stock.noler.com/us/stock/onco/defined-contribution-plan-employers-matching-contribution-annual-vesting-percentage https://stock.noler.com/us/stock/onco/deposit-liabilities-accrued-interest https://stock.noler.com/us/stock/onco/deposits https://stock.noler.com/us/stock/onco/deposits-assets-noncurrent https://stock.noler.com/us/stock/onco/depreciation https://stock.noler.com/us/stock/onco/depreciation-and-amortization https://stock.noler.com/us/stock/onco/depreciation-and-amortization-expense https://stock.noler.com/us/stock/onco/derivative-fair-value-of-derivative-net https://stock.noler.com/us/stock/onco/derivative-fixed-interest-rate https://stock.noler.com/us/stock/onco/derivative-liabilities https://stock.noler.com/us/stock/onco/derivative-liabilities-current https://stock.noler.com/us/stock/onco/derivative-variable-interest-rate https://stock.noler.com/us/stock/onco/development-costs https://stock.noler.com/us/stock/onco/diluted-shares https://stock.noler.com/us/stock/onco/dilutive-shares https://stock.noler.com/us/stock/onco/dividend https://stock.noler.com/us/stock/onco/dividend-safety https://stock.noler.com/us/stock/onco/dividends-paidinkind https://stock.noler.com/us/stock/onco/dividends-payable-amount-per-share https://stock.noler.com/us/stock/onco/dividends-per-share https://stock.noler.com/us/stock/onco/due-from-other-related-parties-current https://stock.noler.com/us/stock/onco/due-from-related-parties https://stock.noler.com/us/stock/onco/due-from-related-parties-current https://stock.noler.com/us/stock/onco/ebitda https://stock.noler.com/us/stock/onco/ebitda-margin https://stock.noler.com/us/stock/onco/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/onco/effective-tax-rate https://stock.noler.com/us/stock/onco/employee-count https://stock.noler.com/us/stock/onco/employee-stock-ownership-plan-esop-compensation-expense https://stock.noler.com/us/stock/onco/eps https://stock.noler.com/us/stock/onco/eps-basic https://stock.noler.com/us/stock/onco/equity-classified-written-call-option-modification-equity-issuance-increase-decrease-in-equity-amount https://stock.noler.com/us/stock/onco/excess-stock-shares-issued https://stock.noler.com/us/stock/onco/excess-stock-shares-outstanding https://stock.noler.com/us/stock/onco/executive-pay-pvp https://stock.noler.com/us/stock/onco/executive-salary-officers https://stock.noler.com/us/stock/onco/expense-breakdown https://stock.noler.com/us/stock/onco/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/onco/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/onco/fair-value-of-assets-acquired https://stock.noler.com/us/stock/onco/fair-value-option-changes-in-fair-value-gain-loss https://stock.noler.com/us/stock/onco/federal-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/onco/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/onco/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/onco/financing-cash-flow https://stock.noler.com/us/stock/onco/financing-interest-expense https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/onco/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/onco/foreign-pretax-income https://stock.noler.com/us/stock/onco/form-144-stocks https://stock.noler.com/us/stock/onco/form-n-port-stocks https://stock.noler.com/us/stock/onco/forward-contract-indexed-to-equity-settlement-share-fair-value-per-share https://stock.noler.com/us/stock/onco/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/onco/gain-loss-on-sales-of-assets-and-asset-impairment-charges https://stock.noler.com/us/stock/onco/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/onco/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/onco/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/onco/general-and-administrative-expense https://stock.noler.com/us/stock/onco/goodwill https://stock.noler.com/us/stock/onco/goodwill-acquired https://stock.noler.com/us/stock/onco/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/onco/goodwill-foreign-currency-translation-gain-loss https://stock.noler.com/us/stock/onco/goodwill-impairment-loss https://stock.noler.com/us/stock/onco/goodwill-impairment-loss-net-of-tax https://stock.noler.com/us/stock/onco/goodwill-transfers https://stock.noler.com/us/stock/onco/grants-receivable https://stock.noler.com/us/stock/onco/graph https://stock.noler.com/us/stock/onco/gross-margin https://stock.noler.com/us/stock/onco/gross-profit https://stock.noler.com/us/stock/onco/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/onco/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/onco/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/onco/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/onco/included-in-etf https://stock.noler.com/us/stock/onco/income-loss-attributable-to-parent https://stock.noler.com/us/stock/onco/income-tax https://stock.noler.com/us/stock/onco/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/onco/income-tax-expense-benefit-adjustment-of-deferred-tax-asset-liability https://stock.noler.com/us/stock/onco/income-taxes-paid https://stock.noler.com/us/stock/onco/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/onco/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/onco/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/onco/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/onco/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/onco/increase-decrease-in-deposit-other-assets https://stock.noler.com/us/stock/onco/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/onco/increase-decrease-in-due-from-related-parties https://stock.noler.com/us/stock/onco/increase-decrease-in-inventories https://stock.noler.com/us/stock/onco/increase-decrease-in-other-deferred-liability https://stock.noler.com/us/stock/onco/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/onco/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/onco/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/onco/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/onco/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/onco/increase-decrease-in-receivable-for-investment-sold https://stock.noler.com/us/stock/onco/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/onco/incremental-common-shares-attributable-to-conversion-of-preferred-stock https://stock.noler.com/us/stock/onco/incremental-common-shares-attributable-to-nonvested-shares-with-forfeitable-dividends https://stock.noler.com/us/stock/onco/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/onco/incremental-common-shares-attributable-to-written-put-options https://stock.noler.com/us/stock/onco/indefinite-lived-trade-names https://stock.noler.com/us/stock/onco/insider-transactions https://stock.noler.com/us/stock/onco/intangible-assets-current https://stock.noler.com/us/stock/onco/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/onco/interest-and-dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/onco/interest-expense https://stock.noler.com/us/stock/onco/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/onco/interest-expense-nonoperating https://stock.noler.com/us/stock/onco/interest-expense-on-debt https://stock.noler.com/us/stock/onco/interest-expense-other https://stock.noler.com/us/stock/onco/interest-paid-net https://stock.noler.com/us/stock/onco/interest-payable-current https://stock.noler.com/us/stock/onco/inventory https://stock.noler.com/us/stock/onco/inventory-adjustments https://stock.noler.com/us/stock/onco/inventory-finished-goods https://stock.noler.com/us/stock/onco/inventory-raw-materials https://stock.noler.com/us/stock/onco/inventory-valuation-reserves https://stock.noler.com/us/stock/onco/inventory-work-in-process https://stock.noler.com/us/stock/onco/inventory-write-down https://stock.noler.com/us/stock/onco/investing-cash-flow https://stock.noler.com/us/stock/onco/investment-income-interest https://stock.noler.com/us/stock/onco/investment-income-investment-expense https://stock.noler.com/us/stock/onco/investment-interest-rate https://stock.noler.com/us/stock/onco/investment-interest-rate-paid-in-cash https://stock.noler.com/us/stock/onco/investment-interest-rate-paid-in-kind https://stock.noler.com/us/stock/onco/investment-owned-at-cost https://stock.noler.com/us/stock/onco/investment-owned-balance-principal-amount https://stock.noler.com/us/stock/onco/investment-owned-balance-shares https://stock.noler.com/us/stock/onco/investments-and-cash https://stock.noler.com/us/stock/onco/iran-activity-notices-irannotice https://stock.noler.com/us/stock/onco/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/onco/labor-and-related-expense https://stock.noler.com/us/stock/onco/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/onco/lease-and-rental-expense https://stock.noler.com/us/stock/onco/lease-cost https://stock.noler.com/us/stock/onco/legal-fees https://stock.noler.com/us/stock/onco/lessee-finance-lease-discount-rate https://stock.noler.com/us/stock/onco/liabilities-assumed https://stock.noler.com/us/stock/onco/liabilities-fair-value-adjustment https://stock.noler.com/us/stock/onco/liabilities-subject-to-compromise-early-contract-termination-fees https://stock.noler.com/us/stock/onco/line-of-credit https://stock.noler.com/us/stock/onco/long-duration-contracts-assumptions-by-product-and-guarantee-discount-rate https://stock.noler.com/us/stock/onco/long-term-notes-payable https://stock.noler.com/us/stock/onco/management-and-service-fees-rate https://stock.noler.com/us/stock/onco/market-cap https://stock.noler.com/us/stock/onco/material-contracts https://stock.noler.com/us/stock/onco/minority-interest https://stock.noler.com/us/stock/onco/net-change-in-cash https://stock.noler.com/us/stock/onco/net-fee-amt https://stock.noler.com/us/stock/onco/net-income https://stock.noler.com/us/stock/onco/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/onco/net-margin https://stock.noler.com/us/stock/onco/news https://stock.noler.com/us/stock/onco/noncash-or-part-noncash-acquisition-inventory-acquired https://stock.noler.com/us/stock/onco/noncash-or-part-noncash-acquisition-payables-assumed https://stock.noler.com/us/stock/onco/noncash-or-part-noncash-divestiture-amount-of-consideration-received https://stock.noler.com/us/stock/onco/noncurrent-assets https://stock.noler.com/us/stock/onco/noninterest-bearing-deposit-liabilities https://stock.noler.com/us/stock/onco/noninterest-expense-offering-cost https://stock.noler.com/us/stock/onco/notes-issued https://stock.noler.com/us/stock/onco/notes-payable https://stock.noler.com/us/stock/onco/notes-payable-current https://stock.noler.com/us/stock/onco/notes-payable-fair-value-disclosure https://stock.noler.com/us/stock/onco/number-of-operating-segments https://stock.noler.com/us/stock/onco/number-of-reportable-segments https://stock.noler.com/us/stock/onco/oci-defined-benefit-plan-net-prior-service-costs-credit-arising-net-of-tax https://stock.noler.com/us/stock/onco/oci-defined-benefit-plans-adjustment-before-tax https://stock.noler.com/us/stock/onco/oci-defined-benefit-plans-adjustment-net-of-tax https://stock.noler.com/us/stock/onco/oci-defined-benefit-plans-net-unamortized-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/onco/oci-finalization-of-pension-and-non-pension-postretirement-plan-valuation-net-of-tax https://stock.noler.com/us/stock/onco/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/onco/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/onco/oci-net-of-tax https://stock.noler.com/us/stock/onco/oci-pension-and-other-postretirement-benefit-plans-adjustment-before-reclassification-adjustments-net-of-tax https://stock.noler.com/us/stock/onco/oci-pension-and-other-postretirement-benefit-plans-net-unamortized-gain-loss-arising-before-tax https://stock.noler.com/us/stock/onco/oci-reclassification-adjustment-from-aoci-pension-and-other-postretirement-benefit-plans-before-tax https://stock.noler.com/us/stock/onco/operating-cash-flow https://stock.noler.com/us/stock/onco/operating-expenses https://stock.noler.com/us/stock/onco/operating-income https://stock.noler.com/us/stock/onco/operating-lease-assets https://stock.noler.com/us/stock/onco/operating-lease-impairment-loss https://stock.noler.com/us/stock/onco/operating-lease-lease-income-lease-payments https://stock.noler.com/us/stock/onco/operating-lease-liability-current https://stock.noler.com/us/stock/onco/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/onco/operating-loss-carryforwards https://stock.noler.com/us/stock/onco/operating-margin https://stock.noler.com/us/stock/onco/option-indexed-to-issuers-equity-settlement-alternatives-shares-at-fair-value https://stock.noler.com/us/stock/onco/options-activity https://stock.noler.com/us/stock/onco/origination-of-notes-receivable-from-related-parties https://stock.noler.com/us/stock/onco/other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/onco/other-accrued-liabilities-current https://stock.noler.com/us/stock/onco/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/onco/other-additional-capital https://stock.noler.com/us/stock/onco/other-asset-impairment-charges https://stock.noler.com/us/stock/onco/other-assets https://stock.noler.com/us/stock/onco/other-assets-miscellaneous-current https://stock.noler.com/us/stock/onco/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/onco/other-commitments-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/onco/other-cost-of-operating-revenue https://stock.noler.com/us/stock/onco/other-current-liabilities https://stock.noler.com/us/stock/onco/other-expenses https://stock.noler.com/us/stock/onco/other-general-and-administrative-expense https://stock.noler.com/us/stock/onco/other-general-expense https://stock.noler.com/us/stock/onco/other-income https://stock.noler.com/us/stock/onco/other-income-2 https://stock.noler.com/us/stock/onco/other-liabilities https://stock.noler.com/us/stock/onco/other-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/onco/other-nonoperating-income-expense https://stock.noler.com/us/stock/onco/other-notes-payable https://stock.noler.com/us/stock/onco/other-notes-payable-current https://stock.noler.com/us/stock/onco/other-operating-income https://stock.noler.com/us/stock/onco/other-operating-income-expense-net https://stock.noler.com/us/stock/onco/other-ownership-interests-offering-costs https://stock.noler.com/us/stock/onco/other-prepaid-expense-current https://stock.noler.com/us/stock/onco/other-receivables https://stock.noler.com/us/stock/onco/other-receivables-gross-current https://stock.noler.com/us/stock/onco/other-receivables-net-current https://stock.noler.com/us/stock/onco/other-research-and-development-expense https://stock.noler.com/us/stock/onco/other-selling-general-and-administrative-expense https://stock.noler.com/us/stock/onco/other-underwriting-expense https://stock.noler.com/us/stock/onco/outstanding-bonds https://stock.noler.com/us/stock/onco/paid-in-capital-other https://stock.noler.com/us/stock/onco/paid-in-capital-share-based-compensation-employee-stock-purchase-program-requisite-service-period-recognition https://stock.noler.com/us/stock/onco/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/onco/paid-in-capital-stock-split https://stock.noler.com/us/stock/onco/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/onco/patents-active https://stock.noler.com/us/stock/onco/payable-preferred-stock-redeemed https://stock.noler.com/us/stock/onco/payments-for-advance-to-affiliate https://stock.noler.com/us/stock/onco/payments-for-fees https://stock.noler.com/us/stock/onco/payments-for-rent https://stock.noler.com/us/stock/onco/payments-for-repurchase-of-initial-public-offering https://stock.noler.com/us/stock/onco/payments-for-repurchase-of-private-placement https://stock.noler.com/us/stock/onco/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/onco/payments-of-financing-costs https://stock.noler.com/us/stock/onco/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/onco/payments-to-acquire-assets-investing-activities https://stock.noler.com/us/stock/onco/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/onco/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/onco/payments-to-acquire-other-productive-assets https://stock.noler.com/us/stock/onco/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/onco/payments-to-acquire-restricted-certificates-of-deposit https://stock.noler.com/us/stock/onco/payments-to-suppliers https://stock.noler.com/us/stock/onco/pb-ratio https://stock.noler.com/us/stock/onco/pe-ratio https://stock.noler.com/us/stock/onco/pension-and-other-postretirement-benefit-contributions https://stock.noler.com/us/stock/onco/pension-and-other-postretirement-benefit-expense https://stock.noler.com/us/stock/onco/pension-and-other-postretirement-benefits-expense-reversal-of-expense-noncash https://stock.noler.com/us/stock/onco/pension-and-other-postretirement-defined-benefit-plans-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/onco/pension-contributions https://stock.noler.com/us/stock/onco/pension-expense https://stock.noler.com/us/stock/onco/pre-tax-margin https://stock.noler.com/us/stock/onco/preferred-shares-facts https://stock.noler.com/us/stock/onco/preferred-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/onco/preferred-stock-convertible-conversion-price https://stock.noler.com/us/stock/onco/preferred-stock-convertible-conversion-price-decrease https://stock.noler.com/us/stock/onco/preferred-stock-convertible-shares-issuable https://stock.noler.com/us/stock/onco/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/onco/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/onco/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/onco/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/onco/preferred-stock-shares-authorized https://stock.noler.com/us/stock/onco/preferred-stock-shares-issued https://stock.noler.com/us/stock/onco/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/onco/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/onco/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/onco/prepaid-expense-current https://stock.noler.com/us/stock/onco/prepaid-expense-noncurrent https://stock.noler.com/us/stock/onco/prepaid-insurance https://stock.noler.com/us/stock/onco/prepaid-rent https://stock.noler.com/us/stock/onco/pretax-income https://stock.noler.com/us/stock/onco/pretax-income-domestic https://stock.noler.com/us/stock/onco/previous-etf-holding-it https://stock.noler.com/us/stock/onco/price-fcf-ratio https://stock.noler.com/us/stock/onco/proceeds-from-contributed-capital https://stock.noler.com/us/stock/onco/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/onco/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/onco/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/onco/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/onco/proceeds-from-issuance-of-preferred-stock-preference-stock-and-warrants https://stock.noler.com/us/stock/onco/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/onco/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/onco/proceeds-from-license-fees-received https://stock.noler.com/us/stock/onco/proceeds-from-notes-payable https://stock.noler.com/us/stock/onco/proceeds-from-related-party-debt https://stock.noler.com/us/stock/onco/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/onco/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/onco/proceeds-from-sale-of-other-investments https://stock.noler.com/us/stock/onco/proceeds-from-secured-lines-of-credit https://stock.noler.com/us/stock/onco/proceeds-from-stock-issued https://stock.noler.com/us/stock/onco/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/onco/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/onco/product-liability-contingency-accrual-discount-rate https://stock.noler.com/us/stock/onco/product-liability-contingency-third-party-recovery-percentage https://stock.noler.com/us/stock/onco/production-related-impairments-or-charges https://stock.noler.com/us/stock/onco/professional-and-contract-services-expense https://stock.noler.com/us/stock/onco/profit-breakdown https://stock.noler.com/us/stock/onco/profit-loss https://stock.noler.com/us/stock/onco/property-plant-equipment https://stock.noler.com/us/stock/onco/ps-ratio https://stock.noler.com/us/stock/onco/public-float https://stock.noler.com/us/stock/onco/quick-ratio https://stock.noler.com/us/stock/onco/range-of-possible-loss-portion-not-accrued https://stock.noler.com/us/stock/onco/reclassifications-of-temporary-to-permanent-equity https://stock.noler.com/us/stock/onco/recognition-of-deferred-revenue https://stock.noler.com/us/stock/onco/redeemable-preferred-stock-dividends https://stock.noler.com/us/stock/onco/regulated-and-unregulated-operating-revenue https://stock.noler.com/us/stock/onco/related-party-costs https://stock.noler.com/us/stock/onco/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/onco/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/onco/related-party-transaction-selling-general-and-administrative-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/onco/repayments-of-notes-payable https://stock.noler.com/us/stock/onco/research-and-development https://stock.noler.com/us/stock/onco/research-and-development-expense-software-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/onco/restricted-cash https://stock.noler.com/us/stock/onco/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/onco/restricted-cash-current https://stock.noler.com/us/stock/onco/restricted-stock-shares-issued-net-of-shares-for-tax-withholdings https://stock.noler.com/us/stock/onco/restricted-stock-value-shares-issued-net-of-tax-withholdings https://stock.noler.com/us/stock/onco/restructuring-settlement-and-impairment-provisions https://stock.noler.com/us/stock/onco/retained-earnings https://stock.noler.com/us/stock/onco/retained-earnings-appropriated https://stock.noler.com/us/stock/onco/return-on-tangible-equity https://stock.noler.com/us/stock/onco/revenue https://stock.noler.com/us/stock/onco/revenue-breakdown https://stock.noler.com/us/stock/onco/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/onco/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/onco/revenues-net-of-interest-expense https://stock.noler.com/us/stock/onco/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/onco/roa https://stock.noler.com/us/stock/onco/roe https://stock.noler.com/us/stock/onco/roi https://stock.noler.com/us/stock/onco/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/onco/sale-of-stock-price-per-share https://stock.noler.com/us/stock/onco/sales-type-lease-revenue https://stock.noler.com/us/stock/onco/scorecard https://stock.noler.com/us/stock/onco/sec-comment-letters-upload https://stock.noler.com/us/stock/onco/sec-enforcement-actions https://stock.noler.com/us/stock/onco/sec-filings-10-q https://stock.noler.com/us/stock/onco/sec-filings-25-nse https://stock.noler.com/us/stock/onco/sec-filings-8-k https://stock.noler.com/us/stock/onco/sec-filings-px14a6g https://stock.noler.com/us/stock/onco/sec-filings-s-4 https://stock.noler.com/us/stock/onco/secondary-offerings https://stock.noler.com/us/stock/onco/servicing-liability-at-fair-value-additions https://stock.noler.com/us/stock/onco/servicing-liability-at-fair-value-amount https://stock.noler.com/us/stock/onco/servicing-liability-at-fair-value-other-changes-in-fair-value https://stock.noler.com/us/stock/onco/sga-expense https://stock.noler.com/us/stock/onco/share-based-goods-and-nonemployee-services-transaction-valuation-method-expected-volatility-rate https://stock.noler.com/us/stock/onco/share-based-goods-and-nonemployee-services-transaction-valuation-method-risk-free-interest-rate https://stock.noler.com/us/stock/onco/share-price https://stock.noler.com/us/stock/onco/shareholders-equity https://stock.noler.com/us/stock/onco/shares-authorized https://stock.noler.com/us/stock/onco/shares-held-in-employee-stock-option-plan-allocated https://stock.noler.com/us/stock/onco/shares-issued https://stock.noler.com/us/stock/onco/shares-issued-2 https://stock.noler.com/us/stock/onco/shares-issued-for-acquisitions https://stock.noler.com/us/stock/onco/shares-issued-price-per-share https://stock.noler.com/us/stock/onco/shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/onco/shares-outstanding https://stock.noler.com/us/stock/onco/shares-outstanding-2 https://stock.noler.com/us/stock/onco/shares-paid-for-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/onco/short-sale-volume https://stock.noler.com/us/stock/onco/short-term-debt-interest-rate-increase https://stock.noler.com/us/stock/onco/short-term-lease-payments https://stock.noler.com/us/stock/onco/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/onco/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/onco/stock-award-fair-value-assumptions-expected-dividend-payments https://stock.noler.com/us/stock/onco/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/onco/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/onco/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/onco/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/onco/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/onco/stock-award-per-share-weighted-average-price-of-shares-purchased https://stock.noler.com/us/stock/onco/stock-award-purchase-price-of-common-stock-percent https://stock.noler.com/us/stock/onco/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/onco/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/onco/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/onco/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/onco/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/onco/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/onco/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/onco/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/onco/stock-based-compensation https://stock.noler.com/us/stock/onco/stock-granted-value-share-based-compensation https://stock.noler.com/us/stock/onco/stock-granted-value-share-based-compensation-forfeited https://stock.noler.com/us/stock/onco/stock-issued-new-shares-sold https://stock.noler.com/us/stock/onco/stock-issued-shares-issued-shares-conversion-of-units https://stock.noler.com/us/stock/onco/stock-issued-shares-issued-shares-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/onco/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/onco/stock-issued-shares-issued-value-employee-benefit-plan https://stock.noler.com/us/stock/onco/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/onco/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/onco/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/onco/stock-issued-shares-issued-value-stock-options-exercised-net-of-tax-benefit-expense https://stock.noler.com/us/stock/onco/stock-issued-shares-issued-value-treasury-stock-reissued https://stock.noler.com/us/stock/onco/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/onco/stock-option-exercise-price-decrease https://stock.noler.com/us/stock/onco/stock-option-exercise-price-increase https://stock.noler.com/us/stock/onco/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/onco/stock-options-exercisable-number https://stock.noler.com/us/stock/onco/stock-options-grants-in-period https://stock.noler.com/us/stock/onco/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/onco/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/onco/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/onco/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/onco/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/onco/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/onco/stock-options-outstanding-number https://stock.noler.com/us/stock/onco/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/onco/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/onco/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/onco/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/onco/stock-redeemed-or-called-shares https://stock.noler.com/us/stock/onco/stock-redeemed-or-called-value https://stock.noler.com/us/stock/onco/stock-repurchase-program-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/onco/stock-repurchase-program-number-of-shares-authorized-to-be-repurchased-2 https://stock.noler.com/us/stock/onco/stock-repurchase-program-remaining-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/onco/stock-splits https://stock.noler.com/us/stock/onco/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/onco/subsidiaries https://stock.noler.com/us/stock/onco/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/onco/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/onco/tax-rate-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/onco/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/onco/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/onco/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/onco/tax-rate-reconciliation-repatriation-of-foreign-earnings https://stock.noler.com/us/stock/onco/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-amount https://stock.noler.com/us/stock/onco/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/onco/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/onco/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/onco/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/onco/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/onco/tax-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/onco/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/onco/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/onco/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/onco/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/onco/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/onco/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/onco/taxes-and-licenses https://stock.noler.com/us/stock/onco/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/onco/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/onco/temporary-equity-redemption-price-per-share https://stock.noler.com/us/stock/onco/total-assets https://stock.noler.com/us/stock/onco/total-liabilities https://stock.noler.com/us/stock/onco/total-liabilities-and-equity https://stock.noler.com/us/stock/onco/treasury-stock-acquired-average-cost-per-share https://stock.noler.com/us/stock/onco/treasury-stock-common-shares https://stock.noler.com/us/stock/onco/treasury-stock-common-value https://stock.noler.com/us/stock/onco/treasury-stock-value https://stock.noler.com/us/stock/onco/ttl-fee-amt https://stock.noler.com/us/stock/onco/ttl-offering-amt https://stock.noler.com/us/stock/onco/ttl-offset-amt https://stock.noler.com/us/stock/onco/ttl-prevsly-pd-amt https://stock.noler.com/us/stock/onco/unbilled-receivables-current https://stock.noler.com/us/stock/onco/underwriting-expense-ratio https://stock.noler.com/us/stock/onco/unrecognized-tax-benefits https://stock.noler.com/us/stock/onco/utb-change https://stock.noler.com/us/stock/onco/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/onco/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/onco/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/onco/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/onco/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/onco/value-added-tax-receivable-current https://stock.noler.com/us/stock/onco/warrant-down-round-feature-increase-decrease-in-equity-amount https://stock.noler.com/us/stock/onco/warrant-exercise-price-decrease https://stock.noler.com/us/stock/onco/warrant-exercise-price-increase https://stock.noler.com/us/stock/onco/warrants-and-rights-outstanding https://stock.noler.com/us/stock/onco/weighted-average-number-of-shares-common-stock-subject-to-repurchase-or-cancellation https://stock.noler.com/us/stock/onco/weighted-average-number-of-shares-contingently-issuable https://stock.noler.com/us/stock/onco/weighted-average-number-of-shares-restricted-stock https://stock.noler.com/us/stock/onco/workers-compensation-liability-current